clinical studies and post-marketing experience with VAXIGRIP TETRA and with the Sanofi Pasteur trivalent influenza vaccine, VAXIGRIP thiomersal free. Data from worldwide use of inactivated influenza vaccines, including experience with use of VAXIGRIP TETRA and VAXIGRIP in countries where inactivated influenza vaccines are
Vaxigrip Tetra Drug / Medicine Information - News-Medical.net
Vaxigrip Tetra is a vaccine. This vaccine helps to protect you or your child against influenza (flu). Vaxigrip Tetra is used to prevent flu in persons of 6 months of age...
Vaxigrip Tetra - Sanofi
Vaxigrip Tetra is a prescription flu vaccine developed by Sanofi to protect against four influenza virus strains.
Vaxigrip Tetra is indicated for active immunisation of adults and children from 6 months of age and older for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine.
Vaxigrip. Separate injection sites and separate needles should be used in case of concomitant administration. The immunological response may be reduced if the patient is undergoing immunosuppressant treatment. Following influenza vaccination, false positive results in serology tests using the ELISA method to detect
Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza vaccine (Vaxigrip®).
Vaxigrip. 組與安慰劑組在胎兒、新生兒、嬰兒 及母親安全性結果方面（包括流產、死胎、早產及低出生體重），兩組間並沒有顯著差異。 一個在馬利 (Mali) 進行的臨床研究， Vaxigrip. 組與對照組（四價流行性腦脊髓膜炎疫苗）在早產、死胎 及低出生體重 /
菲流達四價流感疫苗的功效、適應症及副作用｜元氣網
VAXIGRIPTETRA適用於成人及6個月 (含)以上兒童之主動免疫接種，預防此疫苗所涵蓋之兩種A型及兩種B型流感病毒所引起的流感相關疾病。 藥物的主要成分是什麼? 這個藥物該如何使用? 詳見 藥物說明書. 本藥物是成藥?還是需要醫師開立處方箋? 限由醫師使用.
Vaxigrip Tetra - The Australian Immunisation Handbook
Details for Vaxigrip Tetra (influenza) vaccine and its components. Registered for use in people aged ≥6 months. Quadrivalent inactivated influenza vaccine, split virion. Each 0.5 mL monodose pre-filled syringe contains: May contain traces of:
赛诺菲四价流感疫苗凡尔佳 中国获批，开启流感“高质量防护”新时代
2023年2月27日 · 近日，赛诺菲中国宣布，四价流感病毒裂解疫苗—凡尔佳® (VaxigripTetra®)6~35月龄适应症于2023年2月21日获得国家药品监督管理局 (NMPA)上市许可批准。 流感是由流感病毒引起的急性呼吸道传染病，具有抗原性易变、病毒传播迅速的特点，严重危害人们的健康。 数据显示，在全球范围内，每年季节性流感流行会导致约300万~ 500万例重症病例，以及约29万~ 65万例疾病死亡。 其中，儿童是流感的主要易感人群，每年流感流行季儿童 …